JP7330736B2 - 老視を治療及び/又は予防するための医薬組成物 - Google Patents
老視を治療及び/又は予防するための医薬組成物 Download PDFInfo
- Publication number
- JP7330736B2 JP7330736B2 JP2019074519A JP2019074519A JP7330736B2 JP 7330736 B2 JP7330736 B2 JP 7330736B2 JP 2019074519 A JP2019074519 A JP 2019074519A JP 2019074519 A JP2019074519 A JP 2019074519A JP 7330736 B2 JP7330736 B2 JP 7330736B2
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- bimatoprost
- presbyopia
- present disclosure
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
項1.
ビマトプロストを含む老視を治療及び/又は予防するための医薬組成物。
項2.
ビマトプロストの含有量が0.01~0.05w/v%である、項1に記載の医薬組成物。
項3.
pHが6.5~8.0である、項1又は2に記載の医薬組成物。
項4.
点眼液である、項1~3のいずれか1項に記載の医薬組成物。
項5.
1回1滴、1日1回投与することを特徴とする、項4に記載の医薬組成物。
項6.
ビマトプロストを含む老視を改善するための医薬組成物。
項7.
ビマトプロストを含む近見視力を向上させるための医薬組成物。
項8.
ビマトプロストを含む近方加入度数を低減するための医薬組成物。
項9.
ビマトプロストの含有量が0.03w/v%である、項1に記載の医薬組成物。
項10.
ベンザルコニウム塩化物、塩化ナトリウム、リン酸水素ナトリウム水和物、クエン酸水和物、塩酸、及び水酸化ナトリウムをさらに含む、項1に記載の医薬組成物。
Claims (4)
- ビマトプロストを含む老視を治療及び/又は予防するための医薬組成物であって、点眼液である、医薬組成物。
- ビマトプロストの含有量が0.01~0.05w/v%である、請求項1に記載の医薬組成物。
- pHが6.5~8.0である、請求項1又は2に記載の医薬組成物。
- 1回1滴、1日1回投与することを特徴とする、請求項1~3のいずれかに記載の医薬組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019054654 | 2019-03-22 | ||
JP2019054654 | 2019-03-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020158479A JP2020158479A (ja) | 2020-10-01 |
JP7330736B2 true JP7330736B2 (ja) | 2023-08-22 |
Family
ID=72641830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019074519A Active JP7330736B2 (ja) | 2019-03-22 | 2019-04-10 | 老視を治療及び/又は予防するための医薬組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7330736B2 (ja) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6053008B2 (ja) * | 1976-03-08 | 1985-11-22 | 参天製薬株式会社 | 低濃度ピロカルピン点眼液 |
-
2019
- 2019-04-10 JP JP2019074519A patent/JP7330736B2/ja active Active
Non-Patent Citations (4)
Title |
---|
European Ophthalmic Review,2017年,Vol.11, No.2,pp.99-102 |
Invest.Ophthalmol.Vis.Sci.,2007年,Vol.48,pp.3677-3682 |
MEHDI Ophthalmology Journal,2012年,Vol.1, No.1,pp.3-5 |
Vision,1995年,Vol.7,pp.85-89 |
Also Published As
Publication number | Publication date |
---|---|
JP2020158479A (ja) | 2020-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10792288B2 (en) | Preservative free brimonidine and timolol solutions | |
KR101820184B1 (ko) | 방부제가 없는 비마토프로스트 및 티몰롤 용액 | |
KR20180014824A (ko) | 눈의 굴절 이상 치료 방법 및 저장 안정성 조성물 | |
CN108883102A (zh) | 用于治疗远视眼的组合物和方法 | |
CA3140884A1 (en) | Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality | |
WO2020175525A1 (ja) | ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物 | |
HU213272B (en) | Process for producing pharmaceutical composition containing sorbitol for topical treating enhanced intraocular tension | |
JP2023181428A (ja) | 眼科用組成物 | |
JP7330736B2 (ja) | 老視を治療及び/又は予防するための医薬組成物 | |
JP7404658B2 (ja) | 涙液層安定化剤及びマイバム分泌促進剤 | |
KR20190071674A (ko) | 안과용 제제 및 안과용 약 | |
EP4342472A1 (en) | Eye drop for suppressing myopia | |
JP6931493B2 (ja) | 緑内障治療用点眼組成物 | |
JP4736540B2 (ja) | 眼科用粘稠化剤 | |
JP5041761B2 (ja) | 眼粘膜適用製剤 | |
CA3055891A1 (en) | Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient | |
US20230414573A1 (en) | Synergistic ophthalmological composition in a low-concentration dose that is effective in the prevention, control and eradication of presbyopia | |
WO2018174145A1 (en) | Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising umeclidinium as active ingredient | |
JPS6352609B2 (ja) | ||
WO2020138135A1 (ja) | 眼科用組成物 | |
JPS6410497B2 (ja) | ||
JPH078788B2 (ja) | 散瞳作用を有する眼科用医薬組成物 | |
JP2011084575A (ja) | 点眼液 | |
JP2023022567A (ja) | 洗眼組成物 | |
EA041767B1 (ru) | Применение тиотропия для изготовления средства для предупреждения миопии, лечения миопии и/или предупреждения прогрессирования миопии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20190412 |
|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20190424 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220407 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230228 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230419 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230419 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230711 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230809 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7330736 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |